Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (31)

2024

  1. An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing

    Frontiers in Pharmacology, Vol. 15

  2. Colorectal cancer recurrence and its impact on survival after curative surgery: An analysis based on multistate models

    Digestive and Liver Disease, Vol. 56, Núm. 7, pp. 1229-1236

  3. Metabolic syndrome is not associated with erosive hand osteoarthritis: a cross-sectional study using data from the PROCOAC cohort

    Scientific Reports, Vol. 14, Núm. 1

  4. Mitonuclear epistasis involving TP63 and haplogroup Uk: Risk of rapid progression of knee OA in patients from the OAI

    Osteoarthritis and Cartilage, Vol. 32, Núm. 5, pp. 526-534

  5. Prediction of bronchopulmonary dysplasia in very preterm infants: competitive risk model nomogram

    Frontiers in Pediatrics, Vol. 12

2023

  1. A meta-analysis and a functional study support the influence of mtDNA variant m.16519C on the risk of rapid progression of knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 974-984

  2. Epidemiología de la COVID-19 entre el personal de centros sanitarios y sociosanitarios del área sanitaria de A Coruña y Cee: (Pag.-e 101938)

    Semergen: revista española de medicina de familia, Núm. 5, pp. 2-2

  3. Podiatric Skin and Nail Involvement and Biomechanical Pathology in Renal Transplant Recipients: Assessment of the Foot as a Contributing Factor to Their Health

    Healthcare (Switzerland), Vol. 11, Núm. 23

  4. Postoperative Events in Incompatible Living Donor Kidney Transplant Recipients Undergoing Prior Desensitization

    Transplantation Proceedings, Vol. 55, Núm. 7, pp. 1575-1580

  5. Renal profile of patients treated with elvitegravir/ cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 4, pp. 221-226

2022

  1. Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

    Dermatology and Therapy, Vol. 12, Núm. 3, pp. 761-770

  2. Discontinuation due to neuropsychiatric adverse events with efavirenz-and dolutegravir-based antiretroviral therapy: a comparative real-life study

    European Journal of Hospital Pharmacy, Vol. 29, Núm. 4, pp. 207-211

  3. Improving heat and moisture exchanger therapy with a hydrogel base adhesive in laryngectomised patients: An open, randomised, crossover trial

    Journal of Laryngology and Otology, Vol. 136, Núm. 10, pp. 917-924

  4. Persistence and Waning of Natural SARS-CoV-2 Antibodies Over 18 Months: Long-Term Durability of IgG Humoral Response in Healthcare Workers

    Journal of General Internal Medicine

  5. Relationship between time from symptom's onset to diagnosis and prognosis in patients with symptomatic colorectal cancer

    BMC cancer, Vol. 22, Núm. 1, pp. 910

  6. Volume tumor impact on melanoma survival assessed using Breslow density

    Journal of the American Academy of Dermatology, Vol. 86, Núm. 6, pp. 1410-1412

  7. mtDNA haplogroup A enhances the effect of obesity on the risk of knee OA in a Mexican population

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. A clinical model including protein biomarkers predicts radiographic knee osteoarthritis: a prospective study using data from the Osteoarthritis Initiative

    Osteoarthritis and Cartilage, Vol. 29, Núm. 8, pp. 1147-1154

  2. Clinical characteristics and prognosis of spinal cord injury in individuals over 75 years old

    Neurocirugia, Vol. 32, Núm. 5, pp. 209-216

  3. Concordance between pressure platform and pedigraph

    Diagnostics, Vol. 11, Núm. 12